Covered recipient · General Payments record
GRAYSON T SUMNER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$760.82
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $467.45 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $167.66 | 4 |
| Lilly USA, LLC | $142.27 | 11 |
| Amgen Inc. | $61.66 | 4 |
| Novo Nordisk AS | $31.55 | 2 |
| Merck Sharp & Dohme Corporation | $17.76 | 1 |
| Corcept Therapeutics | $17.74 | 1 |
| PFIZER INC. | $14.97 | 1 |
| GlaxoSmithKline, LLC. | $13.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920202023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.58 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117394030 | CMS |
| Amgen Inc. | $17.62 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111718767 | CMS |
| Amgen Inc. | $13.08 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117394032 | CMS |
| Amgen Inc. | $15.38 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111718769 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.23 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104767838 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.80 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104212563 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.93 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105542259 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.70 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104622836 | CMS |
| Corcept Therapeutics | $17.74 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117748155 | CMS |
| GlaxoSmithKline, LLC. | $13.84 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116505173 | CMS |
| Lilly USA, LLC | $16.96 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135013837 | CMS |
| Lilly USA, LLC | $17.92 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134990732 | CMS |
| Lilly USA, LLC | $1.56 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135006827 | CMS |
| Lilly USA, LLC | $8.75 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135013839 | CMS |
| Lilly USA, LLC | $15.74 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135007005 | CMS |
| Lilly USA, LLC | $16.82 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135012591 | CMS |
| Lilly USA, LLC | $10.86 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135006829 | CMS |
| Lilly USA, LLC | $10.55 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135007003 | CMS |
| Lilly USA, LLC | $11.21 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135012595 | CMS |
| Lilly USA, LLC | $16.29 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135012593 | CMS |
| Lilly USA, LLC | $15.61 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135013841 | CMS |
| Merck Sharp & Dohme LLC | $17.76 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141794698 | CMS |
| Novo Nordisk Inc | $15.06 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097538850 | CMS |
| Novo Nordisk Inc | $16.49 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096924554 | CMS |
| PFIZER INC. | $14.97 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131450861 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.